Intradermal DNA vaccine delivery using vacuum-controlled, needle-free electroporation

Area of Science:

• Vaccinology
• Biomedical Engineering
• Immunology

Background:

• Intradermal DNA vaccine delivery via electroporation (ID-EP) is clinically promising but typically requires invasive needle electrodes.
• Developing noninvasive, effective DNA vaccine delivery systems is crucial for broader clinical application.

Purpose of the Study:

• To evaluate a novel noninvasive intradermal vacuum electroporation (ID-VEP) system for DNA vaccine delivery.
• To assess the efficacy and immunogenicity of ID-VEP for Middle East Respiratory Syndrome Coronavirus (MERS-CoV) DNA vaccines.

Main Methods:

• Delivery of a MERS-CoV DNA vaccine using a noninvasive ID-VEP device in guinea pigs.
• ID-VEP involves pulling skin into a vacuum chamber with noninvasive electrodes for electroporation.
• Analysis of gene expression, humoral and cellular immune responses, and site reactions.

Main Results:

• ID-VEP successfully delivered DNA vaccines, inducing potent humoral and cellular immune responses.
• Gene expression and immunogenicity correlated with electroporation parameters and vacuum chamber geometry.
• Noninvasive ID-VEP showed comparable immunogenicity to needle-based ID-EP with only transient redness as a side effect.

Conclusions:

• ID-VEP is a novel, reliable, and needle-free method for DNA vaccine delivery.
• The noninvasive nature and repeatability of ID-VEP offer a significant advantage for clinical translation.
• This technology holds potential for effective DNA vaccination strategies.